Cocaine Abuse
|
0.300 |
Biomarker
|
disease |
CTD_human |
E3 Ubiquitin-Protein Ligase SMURF1 in the Nucleus Accumbens Mediates Cocaine Seeking.
|
30158054 |
2018 |
Substance Withdrawal Syndrome
|
0.300 |
Biomarker
|
disease |
CTD_human |
E3 Ubiquitin-Protein Ligase SMURF1 in the Nucleus Accumbens Mediates Cocaine Seeking.
|
30158054 |
2018 |
Drug Withdrawal Symptoms
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
E3 Ubiquitin-Protein Ligase SMURF1 in the Nucleus Accumbens Mediates Cocaine Seeking.
|
30158054 |
2018 |
Withdrawal Symptoms
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
E3 Ubiquitin-Protein Ligase SMURF1 in the Nucleus Accumbens Mediates Cocaine Seeking.
|
30158054 |
2018 |
Cocaine-Related Disorders
|
0.300 |
Biomarker
|
group |
CTD_human |
E3 Ubiquitin-Protein Ligase SMURF1 in the Nucleus Accumbens Mediates Cocaine Seeking.
|
30158054 |
2018 |
Cocaine Dependence
|
0.300 |
Biomarker
|
disease |
CTD_human |
E3 Ubiquitin-Protein Ligase SMURF1 in the Nucleus Accumbens Mediates Cocaine Seeking.
|
30158054 |
2018 |
Tumor Cell Invasion
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
ARHGAP26 upregulation in SKOV3 cells significantly inhibited SMURF1 upregulation-induced cell migration and invasion.
|
31004081 |
2019 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Investigation of the mechanism underlying the effects of SMURF1 in OC revealed that SMURF1 induced OC cell migration and invasion via activation of the Ras homolog family member A/Rho‑associated protein kinase signaling pathway.
|
30542716 |
2019 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Additionally, silencing SMURF1 apparently repressed cell proliferation and invasion capacity of SKOV3 and A2780 cells and markedly attenuated expression of linked proteins such as proliferating cellnuclear antigen, matrix metalloproteinase (MMP)-2, and MMP-9.
|
30672020 |
2019 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Our study firstly demonstrated that Smurf1 may promote glioma cell invasion and suppression of the Smurf1 may provide a novel treatment strategy for glioma.
|
28321604 |
2018 |
Tumor Cell Invasion
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Further experiments illustrated that SMURF1 knockdown significantly inhibited growth and metastasis of 769P cells, while SMURF1 overexpression promoted proliferation, migration and invasion in OSRC-2 cells.
|
28396841 |
2017 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Further experiments illustrated that SMURF1 knockdown significantly inhibited proliferation, migration and invasion of MGC-803 cells, while SMURF1 overexpression prominently promoted these behaviors in SGC-7901 cells.
|
28731194 |
2017 |
Tumor Cell Invasion
|
0.100 |
AlteredExpression
|
phenotype |
BEFREE |
Androgens regulate SMAD ubiquitination regulatory factor-1 expression and prostate cancer cell invasion.
|
25631036 |
2015 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
SMURF1 induction by EGF treatment or by the overexpression of MEK1 or SMURF1 resulted in enhanced cell migration and invasion, whereas SMURF1 knockdown suppressed EGF- or MEK1-induced cell migration and invasion.
|
24241683 |
2013 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Smurf1 is related to physiological manifestations in terms of age-dependent deficiency in bone formation and invasion of tumor cells.
|
23007848 |
2013 |
Tumor Cell Invasion
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
By RNA interference (RNAi), knockdown of SMURF1 in a human pancreatic cancer line with focal amplification (AsPC-1) did not alter cell growth, but led to reduced cell invasion and anchorage-independent growth.
|
21887346 |
2011 |
Carcinogenesis
|
0.080 |
Biomarker
|
phenotype |
BEFREE |
Using this method, we screened for small-molecule modulators of SMAD ubiquitin regulatory factor 1 (SMURF1), which belongs to the NEDD4 family of E3 ubiquitin ligases and is an attractive therapeutic target because of its roles in tumorigenesis.
|
30587574 |
2019 |
Carcinogenesis
|
0.080 |
Biomarker
|
phenotype |
BEFREE |
Smad ubiquitylation regulatory factor 1 (Smurf1) has been identified to play a critical role in bone homeostasis, development, cell cycle regulation and tumorigenesis.
|
29550577 |
2018 |
Carcinogenesis
|
0.080 |
Biomarker
|
phenotype |
BEFREE |
Together with its closely related homolog Smurf1, Smurf2 was initially recognized as a negative regulator of transforming growth factor-β (TGF-β) and bone morphogenetic protein (BMP) signaling, but subsequent studies have expanded its function to regulate many different signaling pathways and play important roles in genomic stability, cell polarity, tissue homeostasis and carcinogenesis.
|
29805305 |
2018 |
Carcinogenesis
|
0.080 |
Biomarker
|
phenotype |
BEFREE |
The HECT-type ubiquitin ligase Smurf1 (Smad ubiquitination regulatory factor-1) plays the prominent role in regulation of bone formation, embryonic development, and tumorigenesis by directing the ubiquitin-proteasomal degradation of specific targets.
|
28881580 |
2017 |
Carcinogenesis
|
0.080 |
Biomarker
|
phenotype |
BEFREE |
Thus, we propose that the PKA-Smurf1-PIPKIγ pathway has an important role in pulmonary tumorigenesis and imposes substantial clinical impact on development of novel diagnostic markers and therapeutic targets for lung cancer treatment.
|
28581524 |
2017 |
Carcinogenesis
|
0.080 |
Biomarker
|
phenotype |
BEFREE |
Smurf1 controls S phase progression and tumorigenesis through Wee1 degradation.
|
28294307 |
2017 |
Carcinogenesis
|
0.080 |
Biomarker
|
phenotype |
BEFREE |
RASSF1A Directly Antagonizes RhoA Activity through the Assembly of a Smurf1-Mediated Destruction Complex to Suppress Tumorigenesis.
|
26825171 |
2016 |
Carcinogenesis
|
0.080 |
AlteredExpression
|
phenotype |
BEFREE |
The covalent modifier Nedd8 is critical for the activation of Smurf1 ubiquitin ligase in tumorigenesis.
|
24821572 |
2014 |
Neoplasm Metastasis
|
0.070 |
AlteredExpression
|
phenotype |
BEFREE |
The findings of the present study indicated that overexpression of SMURF1 may contribute to the malignancy and metastasis of OC.
|
30542716 |
2019 |